Schram, A., Borad, M., Sahai, V., Kamath, S., Kim, R., Liao, C., Oh, D., Ponz-Sarvisé, M., Yachnin, J., Shell, S., Cassier, P., Dotan, E., Florou, V., Moreno, V., Park, J., Tai, D., Schmidt-Kittler, O., Ferté, C., Goyal, L., & Subbiah, V. (n.d.). identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor. European journal of cancer, 174, S116–. http://access.bl.uk/ark:/81055/vdc_100169168863.0x000046